Eleni Michalopoulou
Athens, ESYE31 12462, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Vascular and Myocardial Function in Patients with Type 2 Diabetes and Ischemic Stroke Treated with Dulaglutide or Empagliflozin.
Journal: Medicina (Kaunas, Lithuania)
Published: December 27, 2025
Effects of dapagliflozin and dulaglutide on blood pressure and coronary flow in liver steatosis patients with type 2 diabetes.
Journal: Journal of hypertension
Published: August 09, 2025
Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Neurohumoral and Mitochondrial Activation in Patients With Diabetes.
Journal: Journal of the American Heart Association
Published: February 26, 2025
Effects of 4-month treatment with glycocalyx dietary supplement on endothelial glycocalyx and vascular function after COVID-19 infection.
Journal: European journal of clinical investigation
Published: February 09, 2025
The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment.
Journal: Journal of clinical medicine
Published: November 29, 2024
Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'".
Journal: Journal of the Endocrine Society
Published: November 06, 2024
The Effect of 4-Month Treatment with Glycocalyx Dietary Supplement on Endothelial Glycocalyx Integrity and Vascular Function in Patients with Psoriasis.
Journal: Nutrients
Published: July 22, 2024
Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease.
Journal: Journal of the Endocrine Society
Published: March 31, 2024
Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
Journal: Cardiovascular diabetology
Published: March 17, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026